» Authors » Benjamin Assouline

Benjamin Assouline

Explore the profile of Benjamin Assouline including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 336
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Iglesias J, Assouline B, Chatelain Q, Musayeb Y, Degrauwe S, Roffi M
J Am Heart Assoc . 2025 Mar; :e036642. PMID: 40079326
Background: P2Y inhibitor-based single antiplatelet therapy (SAPT) after drug-eluting stent implantation reduces major bleeding without increasing the risk of major adverse cardiovascular and cerebral events compared with 12-month dual antiplatelet...
2.
Massart N, Ortuno S, Vidal C, Henri S, Roze H, Bougle A, et al.
Eur J Clin Microbiol Infect Dis . 2025 Feb; PMID: 39920427
Ojective: We aim to describe a large, multicenter cohort of patients with bloodstream infection (BSI) acquired during extracorporeal membrane oxygenation (ECMO) support. Methods: We conducted a retrospective observational study in...
3.
Da Costa Rodrigues J, Gazarian C, Maillard J, Albu G, Assouline B, Lador F, et al.
Am J Case Rep . 2025 Feb; 26:e946268. PMID: 39891381
BACKGROUND Portopulmonary hypertension (POPH) is part of Group 1 of the clinical classification of pulmonary hypertension and represents 5-15% of patients with pulmonary hypertension, with a 5-year mortality rate of...
4.
Assouline B, Belli G, Dorgham K, Moyon Q, Coppens A, De Chambrun M, et al.
J Crit Care . 2024 Nov; 85:154945. PMID: 39531899
Purpose: Fever is frequent after extracorporeal membrane oxygenation (ECMO) decannulation. We aimed to evaluate the incidence of post-decannulation fever and describe its causes. Methods: Adult ECMO patients who were successfully...
5.
Giraud R, Assouline B, Bendjelid K
Rev Cardiovasc Med . 2024 Jul; 23(7):252. PMID: 39076913
No abstract available.
6.
Assouline B, Kahn R, Hodali L, Condiotti R, Engel Y, Elyada E, et al.
Nat Commun . 2024 Jul; 15(1):6162. PMID: 39039076
Senescent cells within tumors and their stroma exert complex pro- and anti-tumorigenic functions. However, the identities and traits of these cells, and the potential for improving cancer therapy through their...
7.
Levy D, Saura O, Passarelli M, Lucenteforte M, Lebreton G, Bougle A, et al.
Intensive Care Med . 2024 Jun; 50(8):1287-1297. PMID: 38913095
Purpose: Despite systemic thrombolysis, a few patients with high-risk pulmonary embolism (PE) remain hemodynamically unstable. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a considerable lifesaving therapy but systemic thrombolysis before cannulation...
8.
Levy D, Saura O, Lucenteforte M, Collado Lledo E, Demondion P, Hammoudi N, et al.
Am J Physiol Heart Circ Physiol . 2024 May; 327(1):H131-H137. PMID: 38700470
Right ventricular failure (RVF) is a major cause of early mortality after heart transplantation (HT). Isoproterenol (Iso) has chronotropic, inotropic, and vasodilatory properties, which might improve right ventricle function in...
9.
Giraud R, Assouline B, Perrin N, Bendjelid K, Noble S
Cardiol J . 2024 Mar; 31(1):179-180. PMID: 38436485
No abstract available.
10.
Assouline B, Mentha N, Wozniak H, Donner V, Looyens C, Suppan L, et al.
J Clin Med . 2024 Jan; 13(2). PMID: 38256631
Introduction: Out-of-hospital cardiac arrest (OHCA) is a leading cause of mortality. Despite decades of intensive research and several technological advancements, survival rates remain low. The integration of extracorporeal cardiopulmonary resuscitation...